Utilization of crystal structure information in the modular design of aspartyl and cysteine protease inhibitors.

被引：0
|
作者：
Kalish, VJ [1 ]
机构：
[1] IDUN PHARMACEUT,LA JOLLA,CA 92037
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1997年 / 214卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：50 / COMP
页数：2
相关论文
共 50 条
  • [21] Synthesis of 1-aryl-7-substituted phthalazines as parasite cysteine protease inhibitors.
    Vines, K
    Avery, MA
    Sabnis, YA
    Rosenthal, PJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U193 - U193
  • [22] STRUCTURE-BASED DESIGN OF CALCINEURIN INHIBITORS.
    Kissinger, Charles R.
    Parge, Hans
    Knighton, Daniel
    Pelletier, Laura
    Tempczyk, Anna
    Tatlock, John
    Villafranca, Ernest
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 1996, 52 : C201 - C201
  • [23] Structure-based design of ricin inhibitors.
    Kerwin, SM
    Ravikumar, KS
    Miller, D
    Robertus, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U54 - U54
  • [24] Design, synthesis and SAR analysis of anthrax lethal factor protease inhibitors.
    Tang, C
    Simo, O
    Nagata, M
    Jiao, GS
    O'Malley, S
    Goldman, M
    Crvgar, L
    Nguyen, D
    Hemscheidt, T
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U955 - U955
  • [25] Recent advances in the synthesis, design and selection of cysteine protease inhibitors
    Hernandez, AA
    Roush, WR
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2002, 6 (04) : 459 - 465
  • [26] Structure-based design of ketone-containing human rhinovirus 3C protease inhibitors.
    Dragovich, PS
    Zhou, R
    Webber, SE
    Prins, TJ
    Kwok, AK
    Okano, K
    Fuhrman, SA
    Zalman, LS
    Maldonado, FG
    Brown, EL
    Patick, AK
    Matthews, DA
    Ford, CE
    Brothers, MA
    Meadow, JW
    Ferre, RA
    Binford, SL
    Worland, ST
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U3 - U3
  • [27] Structure-based design of irreversible peptidyl and peptidomimetic human rhinovirus 3C protease inhibitors.
    Dragovich, PS
    Webber, SE
    Fuhrman, SA
    Patick, AK
    Matthews, DA
    Lee, CA
    Tuntland, T
    Prins, TJ
    Marakovits, JT
    Zhou, R
    Tikhe, J
    Ford, CE
    Meador, JW
    Harr, JEV
    Kosa, MB
    Ferre, RA
    Brown, EL
    Binford, SL
    DeLisle, DM
    Worland, ST
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U1233 - U1233
  • [28] Comparative QSAR as a cheminformatics tool in the design of HIV-1 protease inhibitors.
    Garg, R
    Bhhatarai, B
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U778 - U779
  • [29] Recent advances in the design, synthesis and molecular recognition of cyclic HIV protease inhibitors.
    Lam, PYS
    Han, Q
    DeLucca, GV
    Chang, CH
    Jadhav, P
    Ru, Y
    Li, RH
    Kassir, JM
    Eyermann, CJ
    Hodge, CN
    Smallheer, J
    Rodgers, JD
    Bacheler, L
    EricksonViitanen, S
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 122 - MEDI
  • [30] Structure-biased library design:: α-ketoamide inhibitors of cruzain, a cysteine protease involved in Chagas' disease
    Weston, GS
    Grisostomi, C
    Cheng, H
    Lange, M
    Fiorey, M
    Cullinane, ME
    Hardy, L
    Pallai, P
    Hartsough, DS
    Tilton, RF
    RATIONAL APPROACHES TO DRUG DESIGN, 2001, : 65 - 68
12345